Syed Taha Iqbal

Array ( [id] => 15114281 [patent_doc_number] => 20190343773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-14 [patent_title] => TRANSDERMAL DELIVERY OF LARGE AGENTS [patent_app_type] => utility [patent_app_number] => 16/462485 [patent_app_country] => US [patent_app_date] => 2017-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34477 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12117323 [patent_doc_number] => 20180000909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'TREATMENT OF PSYCHOLOGICAL TRAUMA' [patent_app_type] => utility [patent_app_number] => 15/707511 [patent_app_country] => US [patent_app_date] => 2017-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23503 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15707511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14818455 [patent_doc_number] => 10406213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-10 [patent_title] => Injection paradigm for administration of botulinum toxins [patent_app_type] => utility [patent_app_number] => 15/707452 [patent_app_country] => US [patent_app_date] => 2017-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18721 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15707452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12178676 [patent_doc_number] => 20180037612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-08 [patent_title] => 'VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 15/702817 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15962 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15702817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17059008 [patent_doc_number] => 11103590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-31 [patent_title] => Immunostimulant [patent_app_type] => utility [patent_app_number] => 16/329919 [patent_app_country] => US [patent_app_date] => 2017-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 16757 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12117291 [patent_doc_number] => 20180000878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'PREBIOTIC FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 15/649352 [patent_app_country] => US [patent_app_date] => 2017-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 43855 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15649352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16177217 [patent_doc_number] => 20200224185 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-07-16 [patent_title] => A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/315698 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -159 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12022110 [patent_doc_number] => 20170312210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'BOTULINUM NANOEMULSIONS' [patent_app_type] => utility [patent_app_number] => 15/643945 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22227 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16177217 [patent_doc_number] => 20200224185 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-07-16 [patent_title] => A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/315698 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -159 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16177217 [patent_doc_number] => 20200224185 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-07-16 [patent_title] => A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/315698 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -159 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16177217 [patent_doc_number] => 20200224185 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-07-16 [patent_title] => A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/315698 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -159 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16177217 [patent_doc_number] => 20200224185 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-07-16 [patent_title] => A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/315698 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -159 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16177217 [patent_doc_number] => 20200224185 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-07-16 [patent_title] => A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/315698 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -159 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16177217 [patent_doc_number] => 20200224185 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-07-16 [patent_title] => A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/315698 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -159 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16177217 [patent_doc_number] => 20200224185 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-07-16 [patent_title] => A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES [patent_app_type] => utility [patent_app_number] => 16/315698 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -159 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17178567 [patent_doc_number] => 11155802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-26 [patent_title] => Recombinant botulinum neurotoxins with increased duration of effect [patent_app_type] => utility [patent_app_number] => 16/498257 [patent_app_country] => US [patent_app_date] => 2017-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9661 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15035731 [patent_doc_number] => 20190328870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => ADJUVANT COMPOSITION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/305630 [patent_app_country] => US [patent_app_date] => 2017-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7478 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17220724 [patent_doc_number] => 11173207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-16 [patent_title] => Adjuvant compositions [patent_app_type] => utility [patent_app_number] => 16/302074 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27765 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14342891 [patent_doc_number] => 20190153418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => METHOD FOR PURIFICATION AND ACTIVATION OF BOTULINUM NEUROTOXIN [patent_app_type] => utility [patent_app_number] => 16/302088 [patent_app_country] => US [patent_app_date] => 2017-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -51 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17844913 [patent_doc_number] => 11434265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Chimeric neurotoxins [patent_app_type] => utility [patent_app_number] => 16/094254 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 13594 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094254 [rel_patent_id] =>[rel_patent_doc_number] =>)